Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Dapagliflozin
71%
Patient
71%
Glucose
67%
Cells
57%
Therapeutic Procedure
52%
Adipocyte
48%
Plasma
40%
Insulin
37%
Gluconeogenesis
37%
Combination Therapy
37%
Insulin Resistance
34%
Inpatient
33%
Adipose Tissue
33%
Placebo
33%
Obesity
30%
Insulin Sensitivity
30%
Adiponectin
27%
Glucagon-Like Peptide-1 Agonist
25%
Leptin
25%
Insulin Release
25%
Connexin 43
23%
Patient with Type 2 Diabetes
21%
Glucosuria
21%
Cardiovascular Disease
19%
Exenatide
18%
Bone
18%
Gap Junction Protein
17%
Pioglitazone
16%
Heart
16%
Chronic Kidney Disease
16%
Semaglutide
16%
Cell Function
16%
Cardiovascular System
16%
Hyperglycemia
16%
Tissues
16%
Glucose Uptake
16%
Glucagon
15%
Cancer
15%
Glycemic Control
15%
Body Weight
14%
Body Mass Index
14%
Paget's Disease
14%
Diabetes
14%
Lipid Diet
14%
Type 2 Diabetes
14%
Development
14%
Osteocyte
13%
Regulatory Mechanism
13%
Glucose Tolerance
13%
Lifespan
13%
Clinical Trial
13%
Osteoclast
13%
Sarcopenia
12%
Oral Glucose Tolerance Test
12%
White Adipose Tissue
12%
Finerenone
12%
Heart Function
11%
Musculoskeletal Health
11%
Glucagon Like Peptide 1
11%
Mineralocorticoid Antagonist
10%
Kidney
10%
Hypercalcaemia
10%
Serositis
10%
Antidiabetic Agent
10%
Fine-Needle Aspiration
10%
Impaired Glucose Tolerance
10%
Adverse Event
10%
Gene
10%
Cotransporter
10%
Weight Loss
9%
Hyperleptinemia
9%
Cell Communication
9%
Fat
9%
Hypoglycemia
9%
Health Outcomes
9%
Resistance Training
9%
Diabetes Mellitus
9%
Male
9%
Metabolism
8%
Diseases
8%
Liver Disease
8%
Chemotherapeutic Agent
8%
Drug
8%
Empagliflozin
8%
Creatine Phosphate
8%
Pheochromocytoma
8%
Iron
8%
Cannabinoid 1 Receptor
8%
Vascular Disease
8%
Osteoclast Differentiation Factor
8%
Hepatocyte Nuclear Factor 4
8%
Peroxisome Proliferator Activated Receptor
8%
Gonadorelin Agonist
8%
Calcium Excretion
8%
Primary Hyperparathyroidism
8%
Patient with Type 1 Diabetes
8%
Human Study
8%
Physical Activity
8%
Meta-Analysis
8%
Biochemistry, Genetics and Molecular Biology
Connexin
50%
Mouse
48%
Adipocyte
41%
Glucose
32%
Osteocyte
18%
Insulin Release
17%
Chicken
16%
Fat
15%
Knockout Mouse
15%
Dapagliflozin
13%
Lipid Metabolism
13%
Gluconeogenesis
12%
Vascularization
11%
Insulin Resistance
11%
Lipogenesis
11%
Adiponectin
11%
Free Fatty Acids
10%
Ossification
10%
Peptide
10%
Wound Healing
10%
Hyaluronan
8%
Galactose
8%
Pyruvate Kinase
8%
Iron
8%
Dimethyl Sulfoxide
8%
Lipid Droplet
8%
Bile Acid Synthesis
8%
Bile Acid
8%
Syntaxin
8%
Hepatocyte Nuclear Factor 4
8%
Calcium Excretion
8%
Calcium Urine Level
8%
Human Study
8%
Physical Activity
8%
Adenosine Triphosphate
8%
Prostaglandin E2
8%
Titer
8%
Prostaglandin E2
8%
Marker Gene
8%
Microinjection
8%
Mitochondrial Respiration
8%
Retrovirus
8%
Stromal Cell
8%
Arginine
8%
Alternative Splicing
8%
Serine
8%
Protein Kinase
8%
Hepatic Stellate Cell
8%
Acetyl-CoA Synthetase
8%
Peroxisome Proliferator-Activated Receptor Gamma
8%
Drug Efficacy
8%
Lifespan
8%
Adrenergic Receptor
8%
Insulin
8%
Nested Gene
8%
Metabolic Pathway
7%
Electric Potential
7%
Glucose Blood Level
7%
Osteolysis
7%
Excretion
7%
FGF21
6%
Glucose Metabolism
6%
Mouse Model
6%
Development
6%
Lysozyme
6%
Lipolysis
5%
Regulatory Mechanism
5%
Immunity
5%
Apoptosis
5%
Cotransporter
5%
Transmembrane Protein
5%
Glucose Homeostasis
5%
Phenotype
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
27%
Leptin
25%
Mouse
18%
Semaglutide
16%
Pioglitazone
16%
Gap Junction Protein
16%
Empagliflozin
16%
Adiponectin
16%
Dapagliflozin
15%
Obesity
13%
Insulin Resistance
13%
Glucose
10%
Insulin
8%
Vascular Disease
8%
Liraglutide
8%
Bile Acid
8%
Dimethyl Sulfoxide
8%
Liver Injury
8%
Prasterone
8%
Semaglutide
8%
Linagliptin
8%
Hepatocyte Nuclear Factor 4
8%
Nonalcoholic Fatty Liver
8%
Peroxisome Proliferator Activated Receptor
8%
Muscone
8%
Primary Hyperparathyroidism
8%
Hyperleptinemia
8%
Placebo
8%
Glucagon Like Peptide 1 Receptor Agonist
8%
Connexin 43
8%
Breast Cancer
8%
Diseases
8%
Osteosarcoma
8%
Adenosine Triphosphate
8%
Amyloid Protein
8%
Alzheimer's Disease
8%
Synthetase
8%
Acetate Coenzyme A Ligase
8%
Hyperkalemia
8%
Finerenone
8%
Glitazone Derivative
7%
Drug
6%
Antidiabetic Agent
6%
Adverse Event
6%
Diseases
5%
Placebo
5%
Diethylstilbestrol
5%
Osteoporosis
5%
Metastasis
5%